Compugen (CGEN) Cost of Revenue (2009 - 2026)
Compugen recorded quarterly Cost of Revenue of $1.8 million in Q1 2026, down 24.0% quarter-over-quarter from $2.4 million in Q1 2025, and down 24.0% year-over-year from $2.4 million in Q1 2025.
Compugen's Cost of Revenue history runs 2 years deep, the most recent figure standing at $1.8 million for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 392.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 296.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 207.52 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 675,000.00 |
| Dec 31, 2024 | 675,000.00 |
| Sep 30, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 975,000.00 |
| Dec 31, 2022 | 975,000.00 |
| Sep 30, 2021 | 680,000.00 |
| Sep 30, 2021 | 680,000.00 |
| Dec 31, 2020 | 60,000.00 |
| Dec 31, 2020 | 60,000.00 |
| Sep 30, 2018 | 684,000.00 |
| Sep 30, 2018 | 684,000.00 |
| Mar 31, 2018 | 350,000.00 |
| Mar 31, 2018 | 350,000.00 |
| Dec 31, 2016 | 35,000.00 |
| Dec 31, 2016 | 35,000.00 |
| Sep 30, 2016 | 21,000.00 |
| Sep 30, 2016 | 21,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Mar 31, 2016 | 81,000.00 |
| Mar 31, 2016 | 81,000.00 |
| Dec 31, 2015 | 1.04 Mn |
| Dec 31, 2015 | 1.04 Mn |
| Sep 30, 2015 | 201,000.00 |
| Sep 30, 2015 | 201,000.00 |
| Jun 30, 2015 | 148,000.00 |
| Jun 30, 2015 | 148,000.00 |
| Mar 31, 2015 | 382,000.00 |
| Mar 31, 2015 | 382,000.00 |
| Dec 31, 2014 | 987,000.00 |
| Dec 31, 2014 | 987,000.00 |
| Sep 30, 2014 | 741,000.00 |
| Sep 30, 2014 | 741,000.00 |
| Jun 30, 2014 | 859,000.00 |
| Jun 30, 2014 | 859,000.00 |
| Mar 31, 2014 | 757,000.00 |
| Mar 31, 2014 | 757,000.00 |
| Dec 31, 2013 | 810,000.00 |
| Dec 31, 2013 | 810,000.00 |
| Sep 30, 2013 | 1.47 Mn |
| Sep 30, 2013 | 1.47 Mn |
| Jun 30, 2013 | 84,000.00 |
| Jun 30, 2013 | 84,000.00 |
| Mar 31, 2013 | 150,000.00 |
| Mar 31, 2013 | 150,000.00 |
| Dec 31, 2012 | 168,000.00 |
| Dec 31, 2012 | 168,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Dec 31, 2010 | 26,000.00 |
| Dec 31, 2010 | 26,000.00 |
| Sep 30, 2010 | 168,000.00 |
| Sep 30, 2010 | 168,000.00 |
| Jun 30, 2010 | 10,000.00 |
| Jun 30, 2010 | 10,000.00 |
| Mar 31, 2010 | 188,000.00 |
| Mar 31, 2010 | 188,000.00 |
| Sep 30, 2009 | 175,000.00 |
| Sep 30, 2009 | 175,000.00 |
| Jun 30, 2009 | 213,000.00 |
| Jun 30, 2009 | 213,000.00 |
| Mar 31, 2009 | 272,000.00 |
| Mar 31, 2009 | 272,000.00 |